北美过敏反应治疗市场预测至 2028 年 - 按药物类型（肾上腺素、抗组胺药、类固醇、β 激动剂等）、给药途径（口服、肠胃外等）、过敏类型（食物）划分的 COVID-19 影响和区域分析过敏、药物、昆虫叮咬等）和分销渠道（医院药房、零售等）
No. of Pages: 143 | Report Code: TIPRE00023954 | Category: Life Sciences
No. of Pages: 143 | Report Code: TIPRE00023954 | Category: Life Sciences
过敏反应是一种过敏反应，可进一步导致称为过敏性休克的致命疾病。当患者的身体对异物产生反应并产生大量组胺从而引发炎症反应时，就会发生过敏反应。这是一种严重的、危及生命的过敏反应，其症状包括吞咽和呼吸困难、皮肤瘙痒和血压降低。
因此，过敏反应发生率的上升预计将对过敏反应产生巨大的需求未来几年的治疗，预计这将进一步推动过敏反应治疗市场。
随着 COVID-19 大流行的蔓延，人们发现世界各地有相当多的人患有慢性疾病呼吸道疾病，如呼吸道过敏，如过敏性鼻炎、鼻窦炎等。例如，根据美国哮喘和过敏基金会 2020 年 6 月进行的一项调查，共有 2,695 人参与了这项研究，其中 57% 患有哮喘，51% 的家庭成员患有哮喘，63在调查组中，% 有过敏症，66% 的家庭成员有过敏症。因此，迄今为止，COVID-19 对市场的影响被认为是积极的。过敏和哮喘恶化通常是由病毒感染（包括冠状病毒）引发的。因此，在 SARS-CoV-2 大流行的风险分层背景下，远程医疗可以成为提供过敏/免疫学服务的核心。因此，美国过敏学会、哮喘学会和免疫学 (AAAAI) 和美国过敏、哮喘与协会免疫学 (ACAAI) 一直大力倡导推进远程医疗，以扩大过敏/免疫学服务，并在需要的地方最直接地为患者提供服务。为了提供一种在 COVID-19 大流行期间对过敏/免疫学服务进行分类的方法，来自美国和加拿大的过敏/免疫学专家组成的基于共识的特设专家小组制定了服务和患者优先顺序图，以临时调整过敏/免疫学服务。使用经过调整和修改的德尔菲方法迭代地制定建议和反馈以达成共识。这可能有利于市场增长。
北美过敏反应治疗市场预计将从 2021 年的 16.358 亿美元增长到 2021 年的 16.358 亿美元到 2028 年将达到 28.917 亿；预计 2021 年至 2028 年复合年增长率为 8.5%。肾上腺素是治疗过敏反应最有效的药物；然而，各种研究表明，由于药物成本高、可用性低以及对药物使用和过敏发作的认识不足，该药物的利用不足。许多组织正在开发治疗过敏反应的仿制药。 2020年4月，Amphastar Pharmaceuticals 宣布其肾上腺素注射液 USP 30mg/30mL (1mg/mL) 获得 FDA 批准新药申请，该注射液采用多剂量小瓶形式。这种仿制药产品已知与肾上腺素（Endo International 和 Par Pharmaceutical）等效，并且被规定作为过敏反应（1 型）的紧急治疗，包括过敏反应。然而，从事这一领域的参与者数量有限。肾上腺素的需求一直在上升，但产品供应有限。根据皮尤慈善信托基金会的数据，过去几年对肾上腺素自动注射器的需求有所增加，美国的 EpiPen 处方数量从 2011 年的约 250 万份增长到 2015 年的 350 万份。这一增长可归因于学校需求旺盛。
就药物类型而言肾上腺素细分市场占据2020年北美过敏反应治疗市场的最大份额。从给药途径来看，肠外细分市场占据2020年北美过敏反应治疗市场的最大份额。从过敏类型来看，食物过敏细分市场在2020年北美过敏反应治疗市场中占据最大份额。从分销渠道来看，零售药房细分市场在2020年过敏反应治疗市场中占有较大的市场份额。
< strong>
一些准备本北美过敏反应治疗市场报告时参考的主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司包括 Amneal Pharmaceuticals Inc.、Mylan NV、Adamis Pharmaceutical Corporation、Abbott、Pfizer Inc.、Glaxosmithkline Plc.、Merck and Co., Inc.、Teva Pharmaceutical Industries Ltd. 和 ALK-ABELLó。< /p>
按药物类型
给药途径
按过敏类型
按分销渠道
按国家/地区
Strategic insights for North America Anaphylaxis Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,635.8 Million |
| Market Size by 2028 | US$ 2,891.7 Million |
| Global CAGR (2021 - 2028) | 8.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 药物类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Anaphylaxis Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Anaphylaxis Treatment Market is valued at US$ 1,635.8 Million in 2021, it is projected to reach US$ 2,891.7 Million by 2028.
As per our report North America Anaphylaxis Treatment Market, the market size is valued at US$ 1,635.8 Million in 2021, projecting it to reach US$ 2,891.7 Million by 2028. This translates to a CAGR of approximately 8.5% during the forecast period.
The North America Anaphylaxis Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Anaphylaxis Treatment Market report:
The North America Anaphylaxis Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Anaphylaxis Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Anaphylaxis Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Anaphylaxis Treatment Market
